Vaccine-induced Th1-type responses are dominant over Th2-type responses in the short term whereas pre-existing Th2 responses are dominant in the longer term.

Vaccine-induced Th1-type responses are dominant over Th2-type responses in the short term whereas pre-existing Th2 responses are dominant in the longer term.

Item
http://www.wikidata.org/entity/Q41034036
Inulin-derived adjuvants efficiently promote both Th1 and Th2 immune responses.Enhancing efficacy of HIV gag DNA vaccine by local delivery of GM-CSF in murine and macaque models.Potent response of QS-21 as a vaccine adjuvant in the skin when delivered with the Nanopatch, resulted in adjuvant dose sparing.Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivo.Protein vaccination with HPV16 E7/Pep-1 nanoparticles elicits a protective T-helper cell-mediated immune response.Expression, purification and immunological characterization of the transforming protein E7, from cervical cancer-associated human papillomavirus type 16.Epithelial expression of human papillomavirus type 16 E7 protein results in peripheral CD8 T-cell suppression mediated by CD4+CD25+ T cells
P2860

Vaccine-induced Th1-type responses are dominant over Th2-type responses in the short term whereas pre-existing Th2 responses are dominant in the longer term.

Item
http://www.wikidata.org/entity/Q41034036
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Vaccine-induced Th1-type respo ...... e dominant in the longer term.
@en
type
label
Vaccine-induced Th1-type respo ...... e dominant in the longer term.
@en
prefLabel
Vaccine-induced Th1-type respo ...... e dominant in the longer term.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Vaccine-induced Th1-type respo ...... e dominant in the longer term.
@en
P2093
P2860
P304
P31
P356
10.1046/J.1365-3083.1998.00327.X
P433
P478
P50
P577
P5875
P698